Clinical Trial Update: Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind, placebo-controlled trial is evaluating Wu-Chu-Yu Tang for gastroesophageal reflux disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Wu-Chu-Yu Tang

Snippet

Sponsor: China Medical University Hospital | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: UNKNOWN